Works about PAROXETINE

Results: 660

Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre‐Administration in a Randomized, Double‐Blind, Cross‐Over Phase I Trial.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 6, p. 1784, doi. 10.1002/cpt.3618

By:

Becker, Anna M.;
Humbert‐Droz, Mélusine;
Mueller, Lorenz;
Jelušić, Alen;
Tolev, Avram;
Straumann, Isabelle;
Avedisian, Isidora;
Erne, Livio;
Thomann, Jan;
Luethi, Dino;
Grünblatt, Edna;
Meyer zu Schwabedissen, Henriette;
Liechti, Matthias E.

Publication type:

Article

Research to help practitioners and individuals treat mental health issues.

Published in:

Health Care for Women International, 2025, v. 46, n. 5, p. 523, doi. 10.1080/07399332.2025.2494450

By:

Covan, Eleanor Krassen;
Fugate-Whitlock, Elizabeth

Publication type:

Article

Treatment of women with generalized anxiety disorder during the postpartum period with paroxetine: A retrospective analysis of 11 years of clinical data.

Published in:

Health Care for Women International, 2025, v. 46, n. 5, p. 585, doi. 10.1080/07399332.2024.2417956

By:

Bakay, Hasan;
Gica, Sakir;
Uguz, Faruk

Publication type:

Article

A case of paroxetine-induced galactorrhoea with normal serum prolactin level.

Published in:

2010

By:

Chakraborty, Suddhendu;
Sanyal, Debasish;
Bhattacharyya, Ranjan;
Dutta, Subhendu

Publication type:

Case Study

Possible cross-sensitivity between sertraline and paroxetine in a panic disorder patient.

Published in:

Indian Journal of Pharmacology, 2010, v. 42, n. 2, p. 110, doi. 10.4103/0253-7613.64497

By:

Khairkar, Praveen H.;
Bang, Govind M.;
Singh, Adarshlata B.;
Tiple, Prashant G.

Publication type:

Article

Treating the Modern Malaise.

Published in:: Hedgehog Review, 2015, v. 17, n. 3, p. 15
Publication type:: Article

Eficacia y seguridad de paroxetina-alprazolam en casos de trastorno de ansiedad generalizada y depresión.

Published in:

Revista Mexicana de Neurociencia, 2010, v. 11, n. 6, p. 457

By:

Vega Lafarga, Rosa María;
Aceves, Ernesto Mendiola

Publication type:

Article

Abstracts of Oral Presentations.

Published in:: 2011
Publication type:: Abstract

Response to 'Fluctuation of dopamine transporter availability in psychiatric‐onset dementia with Lewy bodies: the dilemma of treatment with antidepressants'.

Published in:

2023

By:

Fujishiro, Hiroshige;
Matsubayashi, Rika;
Torii, Youta;
Iwamoto, Kunihiro

Publication type:

Letter to the Editor

Takotsubo cardiomyopathy as a consequence of acute anxiety in a patient with Alzheimer's disease associated with Lewy body disease.

Published in:

2020

By:

Segers, Kurt;
Mihailescu, Tudor;
Kazadi, Annabelle;
Benoit, Florence;
Surquin, Murielle

Publication type:

Case Study

A case of serial nightmares and oneiroid state under paroxetine for senile depression.

Published in:

Psychogeriatrics, 2012, v. 12, n. 1, p. 54, doi. 10.1111/j.1479-8301.2011.00382.x

By:

KOBAYASHI, Toshiyuki;
YAMAUCHI, Mina

Publication type:

Article

Activation syndrome caused by paroxetine in patients with dementia with Lewy bodies.

Published in:

Psychogeriatrics, 2009, v. 9, n. 3, p. 139, doi. 10.1111/j.1479-8301.2009.00277.x

By:

Kimura, Takemi;
Yuuki, Seiji;
Kuga, Masatoshi;
Hayashida, Hideki;
Furukawa, Hitomi;
Takamatsu, Junichi

Publication type:

Article

Parasomnia overlap disorder caused by paroxetine.

Published in:

Sleep & Biological Rhythms, 2017, v. 15, n. 4, p. 327, doi. 10.1007/s41105-017-0107-9

By:

Esaki, Yuichi;
Kitajima, Tsuyoshi;
Fujishiro, Hiroshige;
Fujita, Shiho;
Hirose, Marina;
Watanabe, Akiko;
Iwata, Nakao

Publication type:

Article

Plasma levels of interleukin‐8 and response to paroxetine in patients with major depressive disorder.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 6, p. 1, doi. 10.1002/hup.2855

By:

Guan, Xuan;
Dong, Zai‐Quan;
Hao, Yan‐Ni;
Shen, Xiao‐Ling;
Xie, Qing‐Lian;
Chen, Jian‐Min

Publication type:

Article

Persistent benefits of slow titration of paroxetine in a six-month follow-up.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2015, v. 30, n. 5, p. 329, doi. 10.1002/hup.2478

By:

Olgiati, Paolo;
Serretti, Alessandro

Publication type:

Article

Changes in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorder.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2015, v. 30, n. 5, p. 334, doi. 10.1002/hup.2479

By:

Tomita, Tetsu;
Kaneda, Ayako;
Nakagami, Taku;
Kaneko, Sunao;
Yasui‐Furukori, Norio

Publication type:

Article

Serotonin reuptake inhibitors and breastfeeding: a systematic review.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2015, v. 30, n. 1, p. 4, doi. 10.1002/hup.2451

By:

Orsolini, Laura;
Bellantuono, Cesario

Publication type:

Article

Addition of an NK<sub>1</sub> receptor antagonist to an SSRI did not enhance the antidepressant effects of SSRI monotherapy: results from a randomized clinical trial in patients with major depressive disorder.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 6, p. 568, doi. 10.1002/hup.2444

By:

Ball, William A.;
Snavely, Duane B.;
Hargreaves, Richard J.;
Szegedi, Armin;
Lines, Christopher;
Reines, Scott A.

Publication type:

Article

Benefit of slow titration of paroxetine to treat depression in the elderly.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 6, p. 544, doi. 10.1002/hup.2433

By:

Olgiati, Paolo;
Bajo, Emanuele;
Serretti, Alessandro

Publication type:

Article

Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 1, p. 7, doi. 10.1002/hup.2273

By:

Egami, Maki;
Imamura, Yoshiomi;
Nabeta, Hiromi;
Mizoguchi, Yoshito;
Yamada, Shigeto

Publication type:

Article

Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 8, p. 602, doi. 10.1002/hup.1252

By:

Yasui-Furukori, Norio;
Nakagami, Taku;
Kaneda, Ayako;
Inoue, Yoshimasa;
Suzuki, Akihito;
Otani, Koichi;
Kaneko, Sunao

Publication type:

Article

Association between plasma paroxetine concentration and changes in plasma brain-derived neurotrophic factor levels in patients with major depressive disorder.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 3, p. 194, doi. 10.1002/hup.1192

By:

Yasui-Furukori, Norio;
Tsuchimine, Shoko;
Nakagami, Taku;
Fujii, Akira;
Sato, Yasushi;
Tomita, Tetsu;
Yoshizawa, Kaori;
Inoue, Yoshimasa;
Kaneko, Sunao

Publication type:

Article

Paroxetine augmentation in patients with generalised social anxiety disorder, non-responsive to mirtazapine or placebo.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 1, p. 72, doi. 10.1002/hup.1165

By:

Schutters, Sara I. J.;
van Megen, Harold J. G. M.;
van Veen, J. Frederieke;
Schruers, Koen R. J.;
Westenberg, Herman G. M.

Publication type:

Article

Differences in clinical effect and tolerance between fluvoxamine and paroxetine: A switching study in patients with depression.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2010, v. 25, n. 7/8, p. 525, doi. 10.1002/hup.1147

By:

Suzuki, Yutaro;
Tsuneyama, Nobuto;
Fukui, Naoki;
Sugai, Takuro;
Watanabe, Junzo;
Ono, Shin;
Someya, Toshiyuki

Publication type:

Article

No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2010, v. 25, n. 6, p. 487, doi. 10.1002/hup.1136

By:

Yoshimura, Reiji;
Umene-Nakano, Wakako;
Ueda, Nobuhisa;
Ikenouchi-Sugita, Atsuko;
Hori, Hikaru;
Katsuki, Asuka;
Hayashi, Kenji;
Miyamoto, Kyoko;
Kodama, Yuki;
Nakamura, Jun

Publication type:

Article

Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2009, v. 24, n. 6, p. 489, doi. 10.1002/hup.1043

By:

Yoshimura, Reiji;
Umene-Nakano, Wakako;
Suzuki, Akihito;
Ueda, Nobuhisa;
Miyamoto, Kyoko;
Ikenouchi-Sugita, Atsuko;
Hori, Hikaru;
Otani, Koichi;
Nakamura, Jun

Publication type:

Article

The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: A double-blind crossover trial.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2008, v. 23, n. 5, p. 399, doi. 10.1002/hup.939

By:

Iwamoto, Kunihiro;
Takahashi, Masahiro;
Nakamura, Yukako;
Kawamura, Yukiko;
Ishihara, Ryoko;
Uchiyama, Yuji;
Ebe, Kazutoshi;
Noda, Akiko;
Noda, Yukihiro;
Yoshida, Keizo;
Iidaka, Tetsuya;
Ozaki, Norio

Publication type:

Article

Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.

Published in:

Journal of Pharmacy & Pharmacology, 2022, v. 74, n. 1, p. 67, doi. 10.1093/jpp/rgab138

By:

Figueiredo, Sara;
Fernandes, Ana I;
Carvalho, Fátima G;
Pinto, João F

Publication type:

Article

Precision dosing‐based optimisation of paroxetine during pregnancy for poor and ultrarapid CYP2D6 metabolisers: a virtual clinical trial pharmacokinetics study.

Published in:

Journal of Pharmacy & Pharmacology, 2020, v. 72, n. 8, p. 1049, doi. 10.1111/jphp.13281

By:

Almurjan, Aminah;
Macfarlane, Hannah;
Badhan, Raj K. S.

Publication type:

Article

اثر پاروکستین بر بیان ژن های TLR2 و TLR4 در سلول های تک هسته ای خون محیطی افراد با وضعیت روانی سالم.

Published in:

Medical Journal of Tabriz University of Medical Sciences, 2021, v. 43, n. 3, p. 246

By:

فاطمه گنجعلیشاه&;
آناهید همت پور;
مهدی دهقان منشاد;
حسین هادی ندوشن;
علیرضا کریم اله

Publication type:

Article

Correction to "Synergistic anti‐depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice".

Published in:: 2024
Publication type:: Correction Notice

Development of Taste Masked Orodispersible Film Containing Paroxetine Hydrocloride.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2020, v. 54, p. S98, doi. 10.5530/ijper.54.2s.66

By:

Shinde, Swapnila Vivek;
Phatak, Shraddha;
Awale, Ganesh;
Nikam, Supriya

Publication type:

Article

EFFICACY OF PAROXETINE AND MIRTAZAPINE ON SLEEP IN PATIENTS WITH DEPRESSION AND THEIR RELATIONSHIP WITH POLYSOMNOGRAPHY.

Published in:

Farmacia, 2018, v. 66, n. 1, p. 157

By:

YUNSHU ZHANG;
LILI ZHANG;
HEMIN SHI;
JIANHUA SUN;
SHUHUI GAO;
KEQING LI

Publication type:

Article

Granuloma annulare photoinduced by paroxetine.

Published in:

Photodermatology, Photoimmunology & Photomedicine, 2012, v. 28, n. 1, p. 47, doi. 10.1111/j.1600-0781.2011.00632.x

By:

Álvarez-Pérez, Adriana;
Gómez-Bernal, Silvia;
Gutiérrez-González, Enrique;
Rodríguez-Granados, M. Teresa;
Toribio, Jaime

Publication type:

Article

Erythema multiforme photoinduced by paroxetine and herpes simplex virus.

Published in:

Photodermatology, Photoimmunology & Photomedicine, 2011, v. 27, n. 4, p. 219, doi. 10.1111/j.1600-0781.2011.00600.x

By:

Rodríguez-Pazos, Laura;
Gómez-Bernal, Silvia;
Montero, Iria;
Rodríguez-Granados, MaTeresa;
Toribio, Jaime

Publication type:

Article

Rapid Construction of (−)-Paroxetine and (−)-Femoxetine via an N-Heterocyclic Carbene Catalyzed Homoenolate Addition to Nitroalkenes.

Published in:

Asian Journal of Organic Chemistry, 2014, v. 3, n. 4, p. 442, doi. 10.1002/ajoc.201402031

By:

White, Nicholas A.;
Ozboya, Kerem E.;
Flanigan, Darrin M.;
Rovis, Tomislav

Publication type:

Article

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer's disease mice.

Published in:

Translational Neurodegeneration, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40035-020-00194-2

By:

Ai, Peng-Hui;
Chen, Si;
Liu, Xian-Dong;
Zhu, Xiao-Na;
Pan, Yuan-Bo;
Feng, Dong-Fu;
Chen, Shengdi;
Xu, Nan-Jie;
Sun, Suya

Publication type:

Article

Sex-specific effects of neuromodulatory drugs on normal and stress-induced social dominance and aggression in rats.

Published in:

Psychopharmacology, 2025, v. 242, n. 5, p. 1011, doi. 10.1007/s00213-023-06503-7

By:

Ishaq, Sara;
Zahid, Saadia;
Ahmed, Touqeer

Publication type:

Article

Continuous home cage monitoring of activity and sleep in mice during repeated paroxetine treatment and discontinuation.

Published in:

Psychopharmacology, 2023, v. 240, n. 11, p. 2403, doi. 10.1007/s00213-023-06442-3

By:

Collins, Helen M.;
Pinacho, Raquel;
Tam, S. K. Eric;
Sharp, Trevor;
Bannerman, David M.;
Peirson, Stuart N.

Publication type:

Article

5-HT<sub>3</sub> antagonists decrease discounting rate without affecting sensitivity to reward magnitude in the delay discounting task in mice.

Published in:

Psychopharmacology, 2018, v. 235, n. 9, p. 2619, doi. 10.1007/s00213-018-4954-0

By:

Mori, Marina;
Tsutsui-Kimura, Iku;
Mimura, Masaru;
Tanaka, Kenji F.

Publication type:

Article

Erratum to: The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain.

Published in:

2015

By:

Maj, J.;
Bijak, M.;
Dziedzicka-Wasylewska, M.;
Rogoż, R.;
Rogóż, Z.;
Skuza, G.;
Tokarski, K.

Publication type:

Erratum

Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats.

Published in:

Psychopharmacology, 2015, v. 232, n. 19, p. 3515, doi. 10.1007/s00213-015-4003-1

By:

Amodeo, Leslie;
Greenfield, Venuz;
Humphrey, Danielle;
Varela, Veronica;
Pipkin, Joseph;
Eaton, Shannon;
Johnson, Jelesa;
Plant, Christopher;
Harmony, Zachary;
Wang, Li;
Crawford, Cynthia

Publication type:

Article

Effects of paroxetine on PTSD-like symptoms in mice.

Published in:

Psychopharmacology, 2015, v. 232, n. 13, p. 2303, doi. 10.1007/s00213-014-3861-2

By:

Bentefour, Yassine;
Bennis, Mohamed;
Garcia, René;
M'hamed, Saadia

Publication type:

Article

The CRF receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: Comparison with paroxetine and d-cycloserine.

Published in:

Psychopharmacology, 2013, v. 228, n. 1, p. 97, doi. 10.1007/s00213-013-3020-1

By:

Philbert, J.;
Belzung, C.;
Griebel, G.

Publication type:

Article

Effects of diphenyl diselenide on depressive-like behavior in ovariectomized mice submitted to subchronic stress: involvement of the serotonergic system.

Published in:

Psychopharmacology, 2012, v. 222, n. 4, p. 709, doi. 10.1007/s00213-012-2675-3

By:

Rocha, Juliana;
Gai, Bibiana;
Pinton, Simone;
Sampaio, Tuane;
Nogueira, Cristina;
Zeni, Gilson

Publication type:

Article

Persistent Genital Arousal Disorder: Confluent Patient History of Agitated Depression, Paroxetine Cessation, and a Tarlov Cyst.

Published in:

2014

By:

Eibye, Simone;
Jensen, Hans Mørch

Publication type:

Case Study

Inhibition of TNBC Cell Growth by Paroxetine: Induction of Apoptosis and Blockage of Autophagy Flux.

Published in:

Cancers, 2024, v. 16, n. 5, p. 885, doi. 10.3390/cancers16050885

By:

Huang, Qianrui;
Wu, Mengling;
Pu, Yamin;
Zhou, Junyou;
Zhang, Yiqian;
Li, Ru;
Xia, Yong;
Zhang, Yiwen;
Ma, Yimei

Publication type:

Article

The Association between Selective Serotonin Reuptake Inhibitors (SSRIs) Use and the Risk of Bladder Cancer: A Nationwide Population-Based Cohort Study.

Published in:

Cancers, 2020, v. 12, n. 5, p. 1184, doi. 10.3390/cancers12051184

By:

Liu, Yi-Chun;
Chen, Vincent Chin-Hung;
Lu, Mong-Liang;
Lee, Min-Jing;
McIntyre, Roger S.;
Majeed, Amna;
Lee, Yena;
Chen, Yi-Lung

Publication type:

Article

A randomized placebo-controlled trial of paroxetine for the management of anxiety in chronic obstructive pulmonary disease (PAC Study).

Published in:

Journal of Multidisciplinary Healthcare, 2018, v. 11, p. 287, doi. 10.2147/JMDH.S166022

By:

Usmani, Zafar A;
Carson-Chahhoud, Kristin V;
Esterman, Adrian J;
Smith, Brian J

Publication type:

Article

Spectrofluorimetric protocol for antidepressant drugs in dosage forms and human plasma through derivatization with dansyl chloride.

Published in:

Arabian Journal of Chemistry, 2017, v. 10, p. S3197, doi. 10.1016/j.arabjc.2013.12.015

By:

Omar, Mahmoud A.;
Abdelmageed, Osama H.;
Derayea, Sayed M.;
Attia, Tamer Z.

Publication type:

Article